Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02265510 |
| Title | An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Incyte Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Birmingham | Alabama | United States | Details | |||
| West Hollywood | California | United States | Details | |||
| New Haven | Connecticut | United States | Details | |||
| Atlanta | Georgia | United States | Details | |||
| Chicago | Illinois | United States | Details | |||
| Indianapolis | Indiana | United States | Details | |||
| Hackensack | New Jersey | United States | Details | |||
| New York | New York | United States | Details | |||
| Durham | North Carolina | United States | Details | |||
| Portland | Oregon | United States | Details | |||
| Greenville | South Carolina | United States | Details | |||
| Site 2 | Nashville | Tennessee | United States | Details | ||
| Nashville | Tennessee | United States | Details | |||
| Dallas | Texas | United States | Details |